This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23,
Boston Convention and Exhibition Center

Industry’s Largest & Most Renowned Event to Accelerate Your Therapeutics to Market: Leading Strategies for Expediting R&D and Improving CMC Efficiency

Unparalleled access to new data & case studies from globally recognized speakers across the entire spectrum from discovery, preclinical, clinical development through CMC and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.

Announcing TIDES as a Hybrid Event for 2021

To best meet the needs of both traveling and stay-at-home audiences, TIDES USA 2021 will be a HYBRID event, combining a live experience at the Boston Convention & Exhibition Center and digital experiences that showcase all of the content from the live event with additional keynotes, panel discussions and meeting scheduling to be fully inclusive to those unable to attend in person.

Our commitment to your health & safety are a priority so all our events are run according to official government and local authority guidance in the first instance, as well as any venue or location-specific regulations. In addition, all events follow the ten Informa AllSecure priority commitments [Details].

ACCESS NOVEL SCIENCE ACROSS THE ENTIRE OLIGONUCLEOTIDE, PEPTIDE, AND MRNA SPECTRUM

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES multi track agenda covers the latest science and industry updates across the entire spectrum from discovery, preclinical, clinical development through CMC, Manufacturing and commercialization of therapeutics and vaccines for oligos, peptides, mRNA and genome editing products.  


Oligonucleotide Chemistry, Manufacturing & Controls
Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical
Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls
Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.


Peptide Discovery, Preclinical and Clinical
Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics/Vaccines & Genome Editing
mRNA Therapeutics/Vaccines & Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies, and learn about state-of-the-art technologies for genome editing applications and hear about progress in genome editing delivery

Drug Delivery Innovations
Drug Delivery Innovations

Explore new technologies and approaches in the delivery of macromolecular therapeutics featuring multiple case studies of the delivery of oligonucleotides, peptides, mRNA therapeutics and genome editing delivery strategies. Learn about cutting-edge delivery advances including targeted delivery approaches for oligonucleotides, device-based delivery strategies and oral delivery of peptides.

Looking for Additional Training Opportunities?

Join us at one of our upcoming virtual TIDES training courses.

Informa training courses provide in-depth teaching and discussion about highly technical and scientific topics relevant to the TIDES community that can not be covered at a conference. With 6+ hours of dedicated instruction in a classroom-like (teacher/student) environment, a training course will offer you interactive opportunities with the instructor and fellow attendees so you can get your most pressing questions answered in a much more individualized setting.


Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides from Early Development to Registration
Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides from Early Development to Registration

June 1-3 and September 14-16 (Both Virtual)
Learn how to develop an evolving control strategy for your drug substance — from early development to registration. The course will also discuss the issues and risks that can be developed, addressed and mitigated during development

Learn More & Sign Up
Introduction to Oligonucleotide Conjugate Strategies
Introduction to Oligonucleotide Conjugate Strategies

June 8-10 and October 26-28 (Both Virtual)
Understand how to best design oligonucleotide conjugates — from simple starting building blocks to the full oligonucleotide conjugate. With full consideration of the biological behavior of both the finished molecule and all of its individual components.

Learn More & Sign Up

Looking to present your scientific research?

At TIDES USA 2021, you can sign up to present your very own poster! Any registered delegate is eligible to add a poster presentation to their registration. $150 charge for industry and $0 for Academic/Govt. 


"All Access" In-Person Poster Presenters
"All Access" In-Person Poster Presenters
  • Everything included in the "Digital Experience" pass option ->
  • Dedicated Space in the Exhibit/Poster Hall in Boston to share poster & answer questions with delegates
  • Dedicated Poster Viewing Times in-person during Sept 21-23 conference in Boston
"Digital Experience" Poster Presenters
"Digital Experience" Poster Presenters
  • Dedicated Virtual Room for Your Poster 
  • PDF of Your Poster for Virtual Attendees to View & Download
  • Ability to Post a Pre-Taped Audio or Video Introduction of Your Poster 
  • Dedicated Poster Viewing Times Which Allow Attendees to Visit You in Your Virtual Poster Room to Discuss Your Poster in Real-Time 
  • Ability to Have Face to Face (Shared Video) Virtual Meetings with Attendees Who Visit Your Poster Room

CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. Our 2021 hybrid event will offer you the most flexibility needed during these uncertain times. 

For more information, click the link below or email Mike Dunnet directly at Michael.Dunnet@informa.com.

Informa AllSecure is Informa’s approach to enhanced health and safety standards at our events following COVID-19

Jesper Lau, Ph.D.

VP, Protein and Peptide Chemistry

Novo Nordisk, Denmark

The yearly TIDES conferences are among the most important events within peptide and oligonucleotide discovery and development and it has always been among my high priority to be able to join them. I am thus delighted to learn that Informa Connect will deliver TIDES USA Boston 2020 in a virtual format, and I am convinced that a digital meeting will be extremely appreciated in order to continue the important global communication among the scientific communities during these tough times.